UCB.BR
Ucb SA
Price:  
184.85 
EUR
Volume:  
270,829.00
Belgium | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

UCB.BR EV/EBITDA

-44.9%
Upside

As of 2025-08-02, the EV/EBITDA ratio of Ucb SA (UCB.BR) is 18.03. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. UCB.BR's latest enterprise value is 37,409.17 mil EUR. UCB.BR's TTM EBITDA according to its financial statements is 2,075.00 mil EUR. Dividing these 2 quantities gives us the above UCB.BR EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 7.6x - 13.8x 10.8x
Forward P/E multiples 10.3x - 14.3x 11.4x
Fair Price 74.03 - 140.17 101.82
Upside -60.0% - -24.2% -44.9%
184.85 EUR
Stock Price
101.82 EUR
Fair Price

UCB.BR EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-30 18.08
2025-07-29 18.05
2025-07-28 17.47
2025-07-25 17.40
2025-07-24 17.47
2025-07-23 17.37
2025-07-22 16.88
2025-07-21 16.95
2025-07-18 17.09
2025-07-17 17.01
2025-07-16 16.60
2025-07-15 16.70
2025-07-14 16.88
2025-07-11 16.73
2025-07-10 16.88
2025-07-09 16.66
2025-07-08 16.65
2025-07-07 16.63
2025-07-04 16.53
2025-07-03 16.04
2025-07-02 16.33
2025-07-01 16.34
2025-06-30 16.35
2025-06-27 16.66
2025-06-26 16.52
2025-06-25 16.53
2025-06-24 16.20
2025-06-23 16.11
2025-06-20 15.46
2025-06-19 15.48
2025-06-18 15.24
2025-06-17 15.53
2025-06-16 15.88
2025-06-13 16.02
2025-06-12 16.03
2025-06-11 16.15
2025-06-10 16.15
2025-06-09 15.75
2025-06-06 15.96
2025-06-05 15.95
2025-06-04 15.84
2025-06-03 15.60
2025-06-02 15.89
2025-05-30 15.69
2025-05-29 15.25
2025-05-28 15.21
2025-05-27 15.54
2025-05-26 15.45
2025-05-23 15.22
2025-05-22 15.75